| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CACNA1D MAP9 CALD1 MAP1A MYO5B STXBP5 RDX C10orf90 ANKRD23 DCTN1 GJA1 FMN1 TLN1 ANKRD1 CEP135 DIAPH1 DIAPH3 DMD TNNT2 MLPH MYBPC2 | 1.35e-07 | 1099 | 102 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | CALD1 MAP1A MYO5B RDX FMN1 TLN1 DIAPH1 DIAPH3 DMD TNNT2 MLPH MYBPC2 | 6.05e-06 | 479 | 102 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 6.49e-05 | 134 | 102 | 6 | GO:0003697 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.83e-04 | 308 | 102 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | tubulin binding | 3.46e-04 | 428 | 102 | 9 | GO:0015631 | |
| GeneOntologyBiologicalProcess | ribosome biogenesis | GTPBP4 RPL26 WBP11 NOL6 DDX27 ESF1 SART1 RPL26L1 EIF5B NOL7 NOL8 | 7.84e-07 | 336 | 101 | 11 | GO:0042254 |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 9.97e-07 | 275 | 101 | 10 | GO:0016072 | |
| GeneOntologyBiologicalProcess | rRNA processing | 1.96e-06 | 230 | 101 | 9 | GO:0006364 | |
| GeneOntologyBiologicalProcess | response to muscle stretch | 1.01e-05 | 28 | 101 | 4 | GO:0035994 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | CDK9 GTPBP4 ERCC6 RBBP6 SMC5 NPM2 GJA1 CCT6A JUN BAZ1A ANKRD1 TADA2B | 2.03e-05 | 564 | 101 | 12 | GO:0051052 |
| GeneOntologyBiologicalProcess | organelle assembly | MAP9 ERICH3 CNTRL DYNC2I1 RDX C10orf90 ANKRD23 DCTN1 ANKRD1 CEP135 EIF5B DIAPH3 TNNT2 CFAP53 CCDC40 MYBPC2 IQCG | 3.56e-05 | 1138 | 101 | 17 | GO:0070925 |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | GTPBP4 RPL26 WBP11 NOL6 DDX27 ESF1 SART1 RPL26L1 EIF5B NOL7 NOL8 | 4.43e-05 | 515 | 101 | 11 | GO:0022613 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MAP9 MAP1A CNTRL PARD3B C10orf90 DCTN1 GJA1 CEP135 NINL CDK11B DIAPH3 CCDC40 IQCG | 4.95e-05 | 720 | 101 | 13 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | MAP9 MAP1A CNTRL DYNC2I1 PARD3B C10orf90 DCTN1 GJA1 CEP135 DIAPH1 NINL CDK11B DIAPH3 CFAP53 CCDC40 IQCG | 5.38e-05 | 1058 | 101 | 16 | GO:0007017 |
| GeneOntologyBiologicalProcess | striated muscle cell development | 7.64e-05 | 89 | 101 | 5 | GO:0055002 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 9.71e-05 | 293 | 101 | 8 | GO:0032886 | |
| GeneOntologyBiologicalProcess | chromatin organization | CDK9 ERCC6 KDM5A CHAF1A BAZ1B SMC5 NPM2 RTF1 BAZ1A FAM50A BRPF1 TADA2B RNF20 SPTY2D1 | 1.17e-04 | 896 | 101 | 14 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | CDK9 GTPBP4 RPL26 MAP9 ERCC6 BAZ1B RDX C10orf90 XPC SMC5 DCTN1 NPM2 GJA1 JUN RNF20 CDK11B DIAPH3 | 1.20e-04 | 1256 | 101 | 17 | GO:0051726 |
| GeneOntologyBiologicalProcess | DNA replication | 1.50e-04 | 312 | 101 | 8 | GO:0006260 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 2.00e-04 | 59 | 101 | 4 | GO:0045214 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | CALD1 MAP1A MYO5B RDX ANKRD23 DCTN1 GJA1 FMN1 ANKRD1 DIAPH1 DIAPH3 TNNT2 MYBPC2 FOXC2 | 2.32e-04 | 957 | 101 | 14 | GO:0097435 |
| GeneOntologyBiologicalProcess | DNA metabolic process | CDK9 GTPBP4 ERCC6 RBBP6 CHAF1A XPC SMC5 NPM2 GJA1 CCT6A JUN BAZ1A ANKRD1 TADA2B BOD1L1 | 2.42e-04 | 1081 | 101 | 15 | GO:0006259 |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | RPL26 MAP9 ERCC6 BAZ1B RDX C10orf90 XPC SMC5 DCTN1 NPM2 GJA1 CDK11B DIAPH3 | 2.44e-04 | 845 | 101 | 13 | GO:0010564 |
| GeneOntologyBiologicalProcess | Ral protein signal transduction | 3.52e-04 | 6 | 101 | 2 | GO:0032484 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | CDK9 ERCC6 KDM5A CHAF1A BAZ1B SMC5 NPM2 RTF1 BAZ1A FAM50A BRPF1 TADA2B RNF20 SPTY2D1 | 3.59e-04 | 999 | 101 | 14 | GO:0071824 |
| GeneOntologyBiologicalProcess | apoptotic process involved in heart morphogenesis | 4.91e-04 | 7 | 101 | 2 | GO:0003278 | |
| GeneOntologyBiologicalProcess | lung alveolus development | 5.04e-04 | 75 | 101 | 4 | GO:0048286 | |
| GeneOntologyBiologicalProcess | actin filament-based process | CACNA1D CALD1 MYO5B RDX ANKRD23 GJA1 FMN1 TLN1 ANKRD1 DIAPH1 DIAPH3 TNNT2 MYBPC2 | 5.05e-04 | 912 | 101 | 13 | GO:0030029 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | MAP9 C10orf90 ANKRD23 ANKRD1 CEP135 EIF5B DIAPH3 TNNT2 MYBPC2 | 5.42e-04 | 475 | 101 | 9 | GO:0140694 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | CALD1 MYO5B RDX ANKRD23 GJA1 FMN1 TLN1 ANKRD1 DIAPH1 DIAPH3 TNNT2 MYBPC2 | 5.55e-04 | 803 | 101 | 12 | GO:0030036 |
| GeneOntologyCellularComponent | actin cytoskeleton | CALD1 MYO5B RDX C10orf90 ANKRD23 FMN1 DIAPH1 DIAPH3 TNNT2 FYB1 MLPH CCDC102A IQCG | 4.58e-06 | 576 | 102 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.25e-05 | 290 | 102 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | supramolecular fiber | CACNA1D MAP9 CALD1 MAP1A ANKRD23 DCTN1 GJA1 CCT6A FMN1 ANKRD1 DIAPH1 NINL DIAPH3 DMD TNNT2 CFAP53 NBR1 MYBPC2 | 1.46e-05 | 1179 | 102 | 18 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CACNA1D MAP9 CALD1 MAP1A ANKRD23 DCTN1 GJA1 CCT6A FMN1 ANKRD1 DIAPH1 NINL DIAPH3 DMD TNNT2 CFAP53 NBR1 MYBPC2 | 1.60e-05 | 1187 | 102 | 18 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule organizing center | RBBP6 CEP85L CNTRL DYNC2I1 C10orf90 DCTN1 USO1 ITSN2 CEP135 DIAPH1 NINL LRRCC1 DIAPH3 MLPH CFAP53 | 3.86e-05 | 919 | 102 | 15 | GO:0005815 |
| GeneOntologyCellularComponent | myofibril | 5.80e-05 | 273 | 102 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | primary dendrite | 1.41e-04 | 4 | 102 | 2 | GO:0150001 | |
| GeneOntologyCellularComponent | sarcomere | 2.21e-04 | 249 | 102 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | centrosome | RBBP6 CEP85L CNTRL DYNC2I1 C10orf90 DCTN1 ITSN2 CEP135 DIAPH1 NINL LRRCC1 CFAP53 | 3.71e-04 | 770 | 102 | 12 | GO:0005813 |
| GeneOntologyCellularComponent | B-WICH complex | 6.48e-04 | 8 | 102 | 2 | GO:0110016 | |
| GeneOntologyCellularComponent | centriolar subdistal appendage | 1.03e-03 | 10 | 102 | 2 | GO:0120103 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MAP9 CALD1 MAP1A DCTN1 GJA1 CCT6A FMN1 DIAPH1 NINL DIAPH3 DMD CFAP53 | 1.43e-03 | 899 | 102 | 12 | GO:0099513 |
| GeneOntologyCellularComponent | centriole | 1.56e-03 | 172 | 102 | 5 | GO:0005814 | |
| HumanPheno | Sclerosis of finger phalanx | 1.63e-05 | 8 | 35 | 3 | HP:0100899 | |
| Domain | tRNA-bd_dom | 3.01e-05 | 2 | 103 | 2 | IPR002547 | |
| Domain | WAC_Acf1_DNA_bd | 3.01e-05 | 2 | 103 | 2 | PF10537 | |
| Domain | Ribosomal_L26 | 3.01e-05 | 2 | 103 | 2 | PF16906 | |
| Domain | WAC | 3.01e-05 | 2 | 103 | 2 | PS51136 | |
| Domain | tRNA_bind | 3.01e-05 | 2 | 103 | 2 | PF01588 | |
| Domain | TRBD | 3.01e-05 | 2 | 103 | 2 | PS50886 | |
| Domain | Ribosomal_L26/L24P_euk/arc | 3.01e-05 | 2 | 103 | 2 | IPR005756 | |
| Domain | WSTF_Acf1_Cbp146 | 3.01e-05 | 2 | 103 | 2 | IPR013136 | |
| Domain | FH2 | 7.06e-05 | 15 | 103 | 3 | PS51444 | |
| Domain | FH2_Formin | 7.06e-05 | 15 | 103 | 3 | IPR015425 | |
| Domain | FH2 | 7.06e-05 | 15 | 103 | 3 | PF02181 | |
| Domain | FH2 | 7.06e-05 | 15 | 103 | 3 | SM00498 | |
| Domain | Ribosomal_L24/26_CS | 9.00e-05 | 3 | 103 | 2 | IPR005825 | |
| Domain | Drf_DAD | 9.00e-05 | 3 | 103 | 2 | IPR010465 | |
| Domain | Drf_DAD | 9.00e-05 | 3 | 103 | 2 | PF06345 | |
| Domain | RIBOSOMAL_L24 | 9.00e-05 | 3 | 103 | 2 | PS01108 | |
| Domain | ZZ | 1.25e-04 | 18 | 103 | 3 | PF00569 | |
| Domain | ZF_ZZ_2 | 1.25e-04 | 18 | 103 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.25e-04 | 18 | 103 | 3 | PS01357 | |
| Domain | Znf_ZZ | 1.48e-04 | 19 | 103 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 1.48e-04 | 19 | 103 | 3 | SM00291 | |
| Domain | Znf_FYVE_PHD | 1.64e-04 | 147 | 103 | 6 | IPR011011 | |
| Domain | DDT | 2.98e-04 | 5 | 103 | 2 | SM00571 | |
| Domain | WSD | 2.98e-04 | 5 | 103 | 2 | PF15613 | |
| Domain | WHIM1 | 2.98e-04 | 5 | 103 | 2 | PF15612 | |
| Domain | DDT_dom | 2.98e-04 | 5 | 103 | 2 | IPR018501 | |
| Domain | WHIM1_dom | 2.98e-04 | 5 | 103 | 2 | IPR028942 | |
| Domain | WHIM2_dom | 2.98e-04 | 5 | 103 | 2 | IPR028941 | |
| Domain | Bromodomain_CS | 3.86e-04 | 26 | 103 | 3 | IPR018359 | |
| Domain | DDT | 4.45e-04 | 6 | 103 | 2 | PS50827 | |
| Domain | Zinc_finger_PHD-type_CS | 4.56e-04 | 65 | 103 | 4 | IPR019786 | |
| Domain | KOW | 6.21e-04 | 7 | 103 | 2 | SM00739 | |
| Domain | DAD_dom | 8.25e-04 | 8 | 103 | 2 | IPR014767 | |
| Domain | DAD | 8.25e-04 | 8 | 103 | 2 | PS51231 | |
| Domain | - | 8.45e-04 | 449 | 103 | 9 | 3.30.40.10 | |
| Domain | Znf_PHD-finger | 9.54e-04 | 79 | 103 | 4 | IPR019787 | |
| Domain | Znf_RING/FYVE/PHD | 9.86e-04 | 459 | 103 | 9 | IPR013083 | |
| Domain | Drf_GBD | 1.06e-03 | 9 | 103 | 2 | PF06371 | |
| Domain | FH3_dom | 1.06e-03 | 9 | 103 | 2 | IPR010472 | |
| Domain | GTPase-bd | 1.06e-03 | 9 | 103 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 1.06e-03 | 9 | 103 | 2 | PF06367 | |
| Domain | Drf_FH3 | 1.06e-03 | 9 | 103 | 2 | SM01139 | |
| Domain | Drf_GBD | 1.06e-03 | 9 | 103 | 2 | SM01140 | |
| Domain | BROMODOMAIN_1 | 1.10e-03 | 37 | 103 | 3 | PS00633 | |
| Domain | Bromodomain | 1.19e-03 | 38 | 103 | 3 | PF00439 | |
| Domain | PHD | 1.49e-03 | 89 | 103 | 4 | SM00249 | |
| Domain | BROMODOMAIN_2 | 1.49e-03 | 41 | 103 | 3 | PS50014 | |
| Domain | BROMO | 1.60e-03 | 42 | 103 | 3 | SM00297 | |
| Domain | Bromodomain | 1.60e-03 | 42 | 103 | 3 | IPR001487 | |
| Domain | - | 1.60e-03 | 42 | 103 | 3 | 1.20.920.10 | |
| Domain | GBD/FH3_dom | 1.60e-03 | 11 | 103 | 2 | IPR014768 | |
| Domain | KOW | 1.60e-03 | 11 | 103 | 2 | IPR005824 | |
| Domain | KOW | 1.60e-03 | 11 | 103 | 2 | PF00467 | |
| Domain | GBD_FH3 | 1.60e-03 | 11 | 103 | 2 | PS51232 | |
| Domain | FYVE_2 | 1.60e-03 | 11 | 103 | 2 | PF02318 | |
| Domain | Znf_PHD | 1.61e-03 | 91 | 103 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.89e-03 | 95 | 103 | 4 | PS50016 | |
| Domain | RABBD | 1.92e-03 | 12 | 103 | 2 | PS50916 | |
| Domain | Rab_BD | 1.92e-03 | 12 | 103 | 2 | IPR010911 | |
| Domain | ZF_PHD_1 | 1.96e-03 | 96 | 103 | 4 | PS01359 | |
| Domain | Translation_prot_SH3-like | 3.88e-03 | 17 | 103 | 2 | IPR008991 | |
| Domain | Rib_L2_dom2 | 4.35e-03 | 18 | 103 | 2 | IPR014722 | |
| Domain | - | 4.35e-03 | 18 | 103 | 2 | 2.30.30.30 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 4.40e-05 | 35 | 80 | 4 | M41738 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 5.51e-05 | 37 | 80 | 4 | MM15683 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 9.49e-05 | 81 | 80 | 5 | M748 | |
| Pathway | PID_RHOA_PATHWAY | 1.20e-04 | 45 | 80 | 4 | M12 | |
| Pubmed | RPL26 MAP9 WBP11 CALD1 UNCX MYO5B KDM5A CHAF1A CNTRL NOL6 RDX XPC SREK1 NKIRAS2 TTC3 DCTN1 LETM1 ESF1 OR10G4 MIPOL1 SART1 CCT6A BAZ1A FAM50A RPL26L1 ITSN2 EIF5B BOD1L1 DIAPH3 DMD OR10G9 SPEN SKAP2 MLPH MYBPC2 | 7.01e-23 | 1442 | 103 | 35 | 35575683 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GTPBP4 AIMP1 CHAF1A NOL6 BAZ1B RDX PSMD4 SREK1 TTC3 DCTN1 DDX27 LETM1 YARS1 ESF1 SART1 CCT6A USO1 BAZ1A RPL26L1 TLN1 RNF20 DIAPH1 EIF5B NOL7 BOD1L1 SPEN NBR1 | 6.50e-15 | 1425 | 103 | 27 | 30948266 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | CDK9 GTPBP4 RPL26 WBP11 CHAF1A NOL6 BAZ1B PSMD4 SREK1 DDX27 ESF1 RTF1 SART1 CCT6A RPL26L1 ANKRD1 RNF20 NOL7 BOD1L1 CDK11B SPTY2D1 NOL8 | 1.32e-13 | 989 | 103 | 22 | 36424410 |
| Pubmed | CDK9 GTPBP4 WBP11 RBBP6 CHAF1A TRPS1 BAZ1B CCDC12 SMC5 YARS1 ESF1 RTF1 SART1 CCT6A DNAJC17 BAZ1A FAM50A RNF20 DIAPH1 EIF5B BOD1L1 CDK11B | 2.17e-13 | 1014 | 103 | 22 | 32416067 | |
| Pubmed | CDK9 GTPBP4 RPL26 ERCC6 AIMP1 RBBP6 NOL12 NOL6 BAZ1B XPC SREK1 CCDC12 DCTN1 DDX27 SART1 CCT6A BAZ1A RPL26L1 BRPF1 NOL8 | 6.67e-13 | 847 | 103 | 20 | 35850772 | |
| Pubmed | CDK9 GTPBP4 RPL26 WBP11 CALD1 RBBP6 DCTN1 ESF1 RTF1 SART1 CCT6A TLN1 RNF20 DIAPH1 BOD1L1 | 2.85e-11 | 506 | 103 | 15 | 30890647 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CALD1 CEP85L STXBP5 CNTRL DYNC2I1 PARD3B DCTN1 DDX27 MIPOL1 CCT6A PPP2R5D MAST4 BRPF1 TLN1 ITSN2 CEP135 NINL LRRCC1 | 6.73e-11 | 853 | 103 | 18 | 28718761 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CDK9 GTPBP4 RPL26 WBP11 AIMP1 RDX DCTN1 LETM1 YARS1 RTF1 SART1 CCT6A DNAJC17 PPP2R5D USO1 FAM50A TLN1 RNF20 DIAPH1 EIF5B DIAPH3 NBR1 | 1.41e-10 | 1415 | 103 | 22 | 28515276 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | WBP11 CALD1 RBBP6 CHAF1A NOL6 BAZ1B SREK1 SMC5 ESF1 SART1 JUN BAZ1A EIF5B NOL7 BOD1L1 CDK11B SPEN NOL8 | 4.05e-10 | 954 | 103 | 18 | 36373674 |
| Pubmed | ERCC6 KDM5A RBBP6 CHAF1A NOL6 TRPS1 BAZ1B XPC SREK1 DDX27 ESF1 CCT6A IGFBP5 BAZ1A TLN1 TADA2B ITSN2 EIF5B NOL7 SPEN SPTY2D1 NOL8 | 4.07e-10 | 1497 | 103 | 22 | 31527615 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | GTPBP4 RPL26 ERCC6 AIMP1 RBBP6 NOL6 AGGF1 BAZ1B SMC5 DDX27 ESF1 SART1 BAZ1A NOL7 SPTY2D1 NOL8 | 8.72e-10 | 759 | 103 | 16 | 35915203 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | RBBP6 BAZ1B PSMD4 ESF1 RTF1 SART1 JUN BOD1L1 CDK11B SPEN NOL8 | 8.77e-10 | 283 | 103 | 11 | 30585729 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SECISBP2L GTPBP4 RPL26 WBP11 RBBP6 NOL12 SREK1 DDX27 ESF1 SART1 JUN FAM50A EIF5B CDK11B SPEN NOL8 | 2.09e-09 | 807 | 103 | 16 | 22681889 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | GTPBP4 ERCC6 KDM5A CHAF1A BAZ1B XPC BAZ1A FAM50A BRPF1 TADA2B NOL7 BOD1L1 CDK11B SPEN | 3.54e-09 | 608 | 103 | 14 | 36089195 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CALD1 MAP1A KDM5A XPC SMC5 TTC3 SART1 FAM50A BRPF1 TLN1 TADA2B EIF5B DIAPH3 SPEN NOL8 | 3.88e-09 | 724 | 103 | 15 | 36232890 |
| Pubmed | CDK9 GTPBP4 ERCC6 MAP1A KDM5A RBBP6 CHAF1A NOL12 TRPS1 BAZ1B XPC SREK1 GADD45GIP1 SART1 RASAL3 BRPF1 TADA2B DIAPH1 | 4.76e-09 | 1116 | 103 | 18 | 31753913 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | WBP11 CALD1 MAP1A BAZ1B RDX SART1 CCT6A DNAJC17 FAM50A TLN1 RNF20 CCDC102A | 8.67e-09 | 444 | 103 | 12 | 34795231 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GTPBP4 RPL26 CALD1 MAP1A RBBP6 BAZ1B RDX PSMD4 DCTN1 ESF1 BAZ1A FAM50A TLN1 EIF5B BOD1L1 NOL8 | 1.63e-08 | 934 | 103 | 16 | 33916271 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | GTPBP4 RPL26 CALD1 RBBP6 NOL12 NOL6 RDX DCTN1 DDX27 SART1 CCT6A RPL26L1 TADA2B EIF5B NOL7 CDK11B | 2.04e-08 | 949 | 103 | 16 | 36574265 |
| Pubmed | CDK9 GTPBP4 RPL26 MYO5B RBBP6 RDX PSMD4 UPF3A DCTN1 DDX27 ESF1 SART1 CCT6A USO1 WDR87 TLN1 DIAPH1 EIF5B | 2.61e-08 | 1247 | 103 | 18 | 27684187 | |
| Pubmed | RPL26 WBP11 CALD1 RBBP6 RDX PARD3B SREK1 YARS1 USO1 RPL26L1 RNF20 EIF5B NOL7 NOL8 | 3.11e-08 | 723 | 103 | 14 | 34133714 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | KDM5A CHAF1A TRPS1 AGGF1 DCTN1 GADD45GIP1 YARS1 SART1 JUN USO1 BAZ1A EIF5B SPEN NBR1 FOXC2 | 3.62e-08 | 857 | 103 | 15 | 25609649 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | GTPBP4 RPL26 KDM5A RBBP6 CHAF1A BAZ1B XPC CCDC12 SART1 JUN TMTC3 BAZ1A TADA2B RNF20 NOL7 SPEN SPTY2D1 NOL8 | 4.56e-08 | 1294 | 103 | 18 | 30804502 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | GTPBP4 RPL26 AIMP1 KDM5A RBBP6 CHAF1A NOL6 BAZ1B RDX SREK1 CCDC12 DDX27 YARS1 CCT6A DIAPH1 EIF5B NOL7 CDK11B | 6.01e-08 | 1318 | 103 | 18 | 30463901 |
| Pubmed | GTPBP4 RPL26 WBP11 BAZ1B SREK1 TTC3 DCTN1 DDX27 LETM1 ESF1 GJA1 DNAJC17 PPP2R5D TMTC3 TLN1 EIF5B DIAPH3 NBR1 NOL8 | 6.97e-08 | 1487 | 103 | 19 | 33957083 | |
| Pubmed | SECISBP2L GTPBP4 WBP11 AIMP1 KDM5A NOL6 RDX XPC DDX27 GADD45GIP1 USO1 BAZ1A FAM50A TLN1 TADA2B NOL7 CDK11B SPTY2D1 | 1.08e-07 | 1371 | 103 | 18 | 36244648 | |
| Pubmed | 1.25e-07 | 360 | 103 | 10 | 33111431 | ||
| Pubmed | WBP11 RBBP6 CHAF1A NOL6 PARD3B CCDC12 CCT6A BAZ1A BOD1L1 CDK11B SPEN | 1.56e-07 | 469 | 103 | 11 | 27634302 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | CDK9 GTPBP4 RPL26 ERCC6 MYO5B AIMP1 RBBP6 NOL6 BAZ1B DDX27 YARS1 ESF1 SART1 CCT6A EIF5B SPEN NOL8 | 1.68e-07 | 1257 | 103 | 17 | 36526897 |
| Pubmed | GTPBP4 RPL26 NOL12 NOL6 PSMD4 DDX27 ESF1 EIF5B NOL7 SPTY2D1 NOL8 | 2.09e-07 | 483 | 103 | 11 | 36912080 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | GTPBP4 RPL26 CALD1 AIMP1 RDX PSMD4 NKIRAS2 DCTN1 SART1 CCT6A FAM50A TLN1 RNF20 BOD1L1 | 2.15e-07 | 847 | 103 | 14 | 35235311 |
| Pubmed | MAP1A RBBP6 CHAF1A CNTRL PSMD4 DCTN1 DDX27 JUN RASAL3 ITSN2 DMD | 2.23e-07 | 486 | 103 | 11 | 20936779 | |
| Pubmed | WBP11 CHAF1A DYNC2I1 GJA1 PPP2R5D TMTC3 USO1 CEP135 DIAPH1 BOD1L1 CDK11B NBR1 IQCG | 2.74e-07 | 733 | 103 | 13 | 34672954 | |
| Pubmed | KDM5A RDX ANKRD23 TTC3 DCTN1 CCT6A IGFBP5 TLN1 ANKRD1 SKAP2 MYBPC2 | 2.78e-07 | 497 | 103 | 11 | 23414517 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GTPBP4 WBP11 CALD1 MYO5B NOL6 BAZ1B DDX27 GADD45GIP1 SART1 CCT6A BAZ1A TLN1 EIF5B NOL7 SPEN | 3.57e-07 | 1024 | 103 | 15 | 24711643 |
| Pubmed | RPL26 CHAF1A NOL12 SREK1 DDX27 GADD45GIP1 ESF1 RTF1 RPL26L1 NOL7 | 4.83e-07 | 417 | 103 | 10 | 36537216 | |
| Pubmed | EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration. | 5.01e-07 | 6 | 103 | 3 | 15311282 | |
| Pubmed | 5.01e-07 | 6 | 103 | 3 | 31775559 | ||
| Pubmed | 5.04e-07 | 419 | 103 | 10 | 15635413 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KDM5A RBBP6 CHAF1A BAZ1B XPC ESF1 SART1 JUN BRPF1 RNF20 EIF5B CDK11B SPEN | 5.05e-07 | 774 | 103 | 13 | 15302935 |
| Pubmed | CDK9 GTPBP4 WBP11 AIMP1 RBBP6 BAZ1B DDX27 LETM1 RTF1 CCT6A USO1 TLN1 | 5.60e-07 | 653 | 103 | 12 | 33742100 | |
| Pubmed | GTPBP4 RPL26 AIMP1 RBBP6 TRPS1 SREK1 DCTN1 DDX27 GADD45GIP1 SART1 DIAPH1 EIF5B | 5.79e-07 | 655 | 103 | 12 | 35819319 | |
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 7.00e-07 | 56 | 103 | 5 | 26919559 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CDK9 GTPBP4 WBP11 MAP1A KDM5A RBBP6 NOL12 XPC UPF3A SREK1 SART1 CCT6A EIF5B CDK11B SPEN | 7.12e-07 | 1082 | 103 | 15 | 38697112 |
| Pubmed | CDK9 RPL26 AIMP1 PSMD4 SREK1 DCTN1 LETM1 YARS1 CCT6A PPP2R5D EIF5B BOD1L1 DMD | 8.28e-07 | 809 | 103 | 13 | 32129710 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 8.42e-07 | 341 | 103 | 9 | 32971831 | |
| Pubmed | 8.67e-07 | 251 | 103 | 8 | 31076518 | ||
| Pubmed | RPL26 MAP9 CALD1 MAP1A MYO5B RDX DCTN1 LETM1 YARS1 GJA1 CCT6A USO1 TLN1 ITSN2 LRRCC1 DMD TNNT2 | 1.02e-06 | 1431 | 103 | 17 | 37142655 | |
| Pubmed | GTPBP4 RPL26 WBP11 AIMP1 RBBP6 CCDC12 DDX27 SART1 CCT6A RPL26L1 NOL7 SPEN | 1.81e-06 | 731 | 103 | 12 | 29298432 | |
| Pubmed | CDK9 KDM5A CHAF1A PSMD4 C10orf90 SREK1 SMC5 DCTN1 ESF1 RTF1 CCT6A FAM50A TADA2B RNF20 CEP135 DIAPH3 | 1.82e-06 | 1327 | 103 | 16 | 32694731 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GTPBP4 ERCC6 NOL6 BAZ1B PSMD4 XPC DCTN1 DDX27 ESF1 SART1 CCT6A BAZ1A TLN1 RNF20 DIAPH1 EIF5B | 2.33e-06 | 1353 | 103 | 16 | 29467282 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MAP9 MYO5B CEP85L CNTRL NOL6 RDX DDX27 MIPOL1 CEP135 NINL SPTY2D1 NOL8 | 2.49e-06 | 754 | 103 | 12 | 33060197 |
| Pubmed | GTPBP4 RPL26 WBP11 AIMP1 KDM5A RBBP6 TRPS1 BAZ1B PSMD4 DDX27 GADD45GIP1 CCT6A JUN RPL26L1 TADA2B SPEN | 4.68e-06 | 1429 | 103 | 16 | 35140242 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 5.46e-06 | 148 | 103 | 6 | 32538781 | |
| Pubmed | 5.62e-06 | 549 | 103 | 10 | 38280479 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CDK9 RPL26 CALD1 AIMP1 RDX PSMD4 YARS1 RTF1 CCT6A S100A13 PPP2R5D RPL26L1 TLN1 RNF20 DIAPH1 EIF5B | 5.87e-06 | 1455 | 103 | 16 | 22863883 |
| Pubmed | GTPBP4 RBBP6 RDX YARS1 SART1 CCT6A PPP2R5D TMTC3 BAZ1A RPL26L1 DIAPH1 EIF5B BOD1L1 DIAPH3 NBR1 | 6.52e-06 | 1297 | 103 | 15 | 33545068 | |
| Pubmed | CALD1 CHAF1A TRPS1 AGGF1 PSMD4 LETM1 YARS1 TADA2B RNF20 NOL8 FOXC2 | 6.53e-06 | 689 | 103 | 11 | 36543142 | |
| Pubmed | 6.86e-06 | 332 | 103 | 8 | 37433992 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 6.86e-06 | 332 | 103 | 8 | 32786267 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SECISBP2L WBP11 MYO5B AIMP1 DYNC2I1 DCTN1 ESF1 MIPOL1 SART1 JUN PPP2R5D RPL26L1 NINL EIF5B CCDC40 | 8.11e-06 | 1321 | 103 | 15 | 27173435 |
| Pubmed | 8.19e-06 | 451 | 103 | 9 | 30033366 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 11207596 | ||
| Pubmed | Prevention of connexin-43 remodeling protects against Duchenne muscular dystrophy cardiomyopathy. | 8.69e-06 | 2 | 103 | 2 | 31910160 | |
| Pubmed | SKAP-HOM, a novel adaptor protein homologous to the FYN-associated protein SKAP55. | 8.69e-06 | 2 | 103 | 2 | 9755858 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 10850428 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 29477453 | ||
| Pubmed | Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling. | 8.69e-06 | 2 | 103 | 2 | 10678165 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 31751316 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 32751416 | ||
| Pubmed | Nucleotide excision repair-initiating proteins bind to oxidative DNA lesions in vivo. | 8.69e-06 | 2 | 103 | 2 | 23253478 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17716977 | ||
| Pubmed | Genetic variation in the nucleotide excision repair pathway and colorectal cancer risk. | 8.69e-06 | 2 | 103 | 2 | 17119055 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24743307 | ||
| Pubmed | CCR7-mediated LFA-1 functions in T cells are regulated by 2 independent ADAP/SKAP55 modules. | 8.69e-06 | 2 | 103 | 2 | 22117043 | |
| Pubmed | Dynamic interaction of formin proteins and cytoskeleton in mouse oocytes during meiotic maturation. | 8.69e-06 | 2 | 103 | 2 | 20971793 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22393014 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 32231219 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 30602496 | ||
| Pubmed | Expression of multiple formins in adult tissues and during developmental stages of mouse brain. | 8.97e-06 | 14 | 103 | 3 | 26272686 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 9.33e-06 | 582 | 103 | 10 | 20467437 | |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 9.54e-06 | 248 | 103 | 7 | 27926873 | |
| Pubmed | 1.03e-05 | 251 | 103 | 7 | 28077445 | ||
| Pubmed | 1.07e-05 | 591 | 103 | 10 | 15231748 | ||
| Pubmed | 1.12e-05 | 15 | 103 | 3 | 36351424 | ||
| Pubmed | 1.18e-05 | 472 | 103 | 9 | 38943005 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.30e-05 | 605 | 103 | 10 | 28977666 | |
| Pubmed | SHP-1 dephosphorylates histone H2B to facilitate its ubiquitination during transcription. | 1.37e-05 | 16 | 103 | 3 | 35938192 | |
| Pubmed | CDK9 GTPBP4 CNTRL NOL6 BAZ1B DCTN1 LETM1 YARS1 SART1 CCT6A DMD | 1.51e-05 | 754 | 103 | 11 | 35906200 | |
| Pubmed | 1.74e-05 | 496 | 103 | 9 | 31343991 | ||
| Pubmed | CDK9 WBP11 CALD1 RDX CCDC12 S100A13 JUN BRPF1 TLN1 ITSN2 NOL7 DMD | 1.76e-05 | 916 | 103 | 12 | 32203420 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.89e-05 | 184 | 103 | 6 | 32908313 | |
| Pubmed | 1.99e-05 | 18 | 103 | 3 | 20599664 | ||
| Pubmed | 2.05e-05 | 638 | 103 | 10 | 31182584 | ||
| Pubmed | 2.33e-05 | 191 | 103 | 6 | 20195357 | ||
| Pubmed | The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion. | 2.37e-05 | 56 | 103 | 4 | 11076968 | |
| Pubmed | 2.50e-05 | 653 | 103 | 10 | 22586326 | ||
| Pubmed | The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. | 2.54e-05 | 57 | 103 | 4 | 16462731 | |
| Pubmed | Structural and regulatory roles of muscle ankyrin repeat protein family in skeletal muscle. | 2.60e-05 | 3 | 103 | 2 | 17392382 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 9671755 | ||
| Interaction | MEN1 interactions | CDK9 GTPBP4 RPL26 ERCC6 RBBP6 NOL12 NOL6 TRPS1 BAZ1B XPC SREK1 CCDC12 DCTN1 DDX27 SART1 PPP2R5D BAZ1A RPL26L1 BRPF1 RNF20 EIF5B BOD1L1 SPEN NOL8 | 2.83e-10 | 1029 | 103 | 24 | int:MEN1 |
| Interaction | DDX23 interactions | GTPBP4 WBP11 ERCC6 RBBP6 XPC SREK1 DDX27 ESF1 RTF1 SART1 DNAJC17 FAM50A BRPF1 NBR1 NOL8 | 2.17e-08 | 480 | 103 | 15 | int:DDX23 |
| Interaction | DOT1L interactions | CDK9 GTPBP4 RPL26 ERCC6 AIMP1 RBBP6 NOL12 NOL6 BAZ1B XPC CCDC12 DCTN1 DDX27 SART1 CCT6A BAZ1A RPL26L1 BRPF1 NOL8 | 2.35e-08 | 807 | 103 | 19 | int:DOT1L |
| Interaction | EFTUD2 interactions | CDK9 GTPBP4 RPL26 WBP11 AIMP1 CHAF1A RDX SREK1 CCDC12 SMC5 DCTN1 LETM1 YARS1 RTF1 SART1 CCT6A DNAJC17 PPP2R5D FAM50A TLN1 RNF20 DIAPH1 EIF5B DIAPH3 NBR1 | 5.08e-08 | 1449 | 103 | 25 | int:EFTUD2 |
| Interaction | ZNF330 interactions | CDK9 GTPBP4 WBP11 CHAF1A BAZ1B XPC DDX27 ESF1 RTF1 BAZ1A FAM50A BRPF1 SPTY2D1 NOL8 | 6.31e-08 | 446 | 103 | 14 | int:ZNF330 |
| Interaction | CENPA interactions | CDK9 GTPBP4 ERCC6 CHAF1A BAZ1B XPC ESF1 RTF1 BAZ1A BRPF1 DIAPH1 DIAPH3 NOL8 | 6.55e-08 | 377 | 103 | 13 | int:CENPA |
| Interaction | FGFBP1 interactions | GTPBP4 RPL26 NOL12 NOL6 SREK1 DDX27 ESF1 BAZ1A RPL26L1 SPTY2D1 NOL8 | 8.30e-08 | 257 | 103 | 11 | int:FGFBP1 |
| Interaction | RPSA2 interactions | 8.55e-08 | 152 | 103 | 9 | int:RPSA2 | |
| Interaction | SNRNP40 interactions | WBP11 RBBP6 NOL6 AGGF1 XPC SREK1 CCDC12 DDX27 SART1 CCT6A DNAJC17 ITSN2 CDK11B SPEN SPTY2D1 NOL8 | 1.44e-07 | 637 | 103 | 16 | int:SNRNP40 |
| Interaction | TNIP1 interactions | GTPBP4 RPL26 CALD1 RBBP6 NOL12 NOL6 RDX DCTN1 DDX27 YARS1 SART1 CCT6A RPL26L1 TADA2B CEP135 NINL EIF5B NOL7 CDK11B DMD CFAP53 NBR1 | 1.72e-07 | 1217 | 103 | 22 | int:TNIP1 |
| Interaction | SRSF6 interactions | GTPBP4 RPL26 RBBP6 NOL12 NOL6 SREK1 CCDC12 SMC5 DDX27 RPL26L1 CDK11B SPEN SPTY2D1 NOL8 | 2.74e-07 | 503 | 103 | 14 | int:SRSF6 |
| Interaction | MBD3 interactions | ERCC6 CHAF1A TRPS1 BAZ1B SMC5 GADD45GIP1 MIPOL1 JUN BAZ1A CDK11B SPEN | 3.32e-07 | 295 | 103 | 11 | int:MBD3 |
| Interaction | RPL31 interactions | CDK9 GTPBP4 RPL26 WBP11 NOL12 NOL6 PSMD4 SREK1 DDX27 GADD45GIP1 ESF1 RTF1 FAM50A RPL26L1 SPTY2D1 NOL8 | 3.47e-07 | 680 | 103 | 16 | int:RPL31 |
| Interaction | EZH1 interactions | 4.55e-07 | 92 | 103 | 7 | int:EZH1 | |
| Interaction | ACTC1 interactions | CDK9 GTPBP4 RPL26 WBP11 CALD1 RBBP6 DCTN1 ESF1 RTF1 SART1 CCT6A TLN1 RNF20 DIAPH1 BOD1L1 DMD | 4.55e-07 | 694 | 103 | 16 | int:ACTC1 |
| Interaction | LINC02910 interactions | 5.67e-07 | 95 | 103 | 7 | int:LINC02910 | |
| Interaction | H3C1 interactions | CDK9 GTPBP4 WBP11 ERCC6 KDM5A CHAF1A NOL6 BAZ1B XPC SMC5 DDX27 DNAJC17 BAZ1A FAM50A WDR87 BRPF1 TADA2B SPEN | 6.53e-07 | 901 | 103 | 18 | int:H3C1 |
| Interaction | GNL2 interactions | GTPBP4 RPL26 MAP9 WBP11 MAP1A NOL12 SMC5 DDX27 ESF1 DNAJC17 RPL26L1 CDK11B | 6.56e-07 | 386 | 103 | 12 | int:GNL2 |
| Interaction | BIRC3 interactions | GTPBP4 AIMP1 CHAF1A NOL6 BAZ1B PSMD4 TTC3 DCTN1 LETM1 YARS1 SART1 CCT6A USO1 BAZ1A RPL26L1 TLN1 RNF20 DIAPH1 EIF5B NOL7 SPEN NBR1 | 8.20e-07 | 1334 | 103 | 22 | int:BIRC3 |
| Interaction | XRCC6 interactions | CDK9 RBBP6 CHAF1A BAZ1B PSMD4 XPC SMC5 ESF1 RTF1 SART1 CCT6A JUN BAZ1A DIAPH1 BOD1L1 CDK11B SPEN NOL8 | 9.99e-07 | 928 | 103 | 18 | int:XRCC6 |
| Interaction | KIF11 interactions | 1.13e-06 | 267 | 103 | 10 | int:KIF11 | |
| Interaction | GPATCH1 interactions | 1.63e-06 | 111 | 103 | 7 | int:GPATCH1 | |
| Interaction | MAGEB2 interactions | GTPBP4 RPL26 RBBP6 NOL12 NOL6 SREK1 DDX27 RPL26L1 CDK11B SPTY2D1 NOL8 | 1.73e-06 | 349 | 103 | 11 | int:MAGEB2 |
| Interaction | MECP2 interactions | CDK9 GTPBP4 WBP11 MAP1A KDM5A RBBP6 NOL12 NOL6 XPC UPF3A SREK1 SMC5 ESF1 SART1 CCT6A BAZ1A RPL26L1 EIF5B CDK11B SPEN NOL8 | 1.82e-06 | 1287 | 103 | 21 | int:MECP2 |
| Interaction | NIFK interactions | GTPBP4 RBBP6 NOL12 SREK1 SMC5 DDX27 GADD45GIP1 ESF1 RTF1 RPL26L1 SPTY2D1 NOL8 | 2.07e-06 | 431 | 103 | 12 | int:NIFK |
| Interaction | NAA40 interactions | GTPBP4 RPL26 CALD1 MAP1A RBBP6 BAZ1B RDX PSMD4 XPC SMC5 DCTN1 ESF1 BAZ1A FAM50A TLN1 EIF5B BOD1L1 NOL8 | 2.11e-06 | 978 | 103 | 18 | int:NAA40 |
| Interaction | DST interactions | 2.16e-06 | 287 | 103 | 10 | int:DST | |
| Interaction | HECTD1 interactions | GTPBP4 RPL26 ERCC6 AIMP1 RBBP6 NOL6 AGGF1 BAZ1B SMC5 DCTN1 DDX27 ESF1 SART1 PPP2R5D BAZ1A NOL7 SPTY2D1 NOL8 | 2.30e-06 | 984 | 103 | 18 | int:HECTD1 |
| Interaction | PARP1 interactions | CDK9 GTPBP4 ERCC6 CALD1 MYO5B NOL6 BAZ1B XPC SREK1 SMC5 DDX27 ESF1 RTF1 SART1 GJA1 CCT6A JUN USO1 BAZ1A FAM50A NOL8 | 2.58e-06 | 1316 | 103 | 21 | int:PARP1 |
| Interaction | NLE1 interactions | 2.59e-06 | 228 | 103 | 9 | int:NLE1 | |
| Interaction | SUPT16H interactions | CDK9 CHAF1A BAZ1B XPC SREK1 SMC5 DCTN1 RTF1 CCT6A RNF20 CDK11B DIAPH3 | 2.69e-06 | 442 | 103 | 12 | int:SUPT16H |
| Interaction | SMC5 interactions | WBP11 CALD1 RBBP6 CHAF1A NOL6 BAZ1B SREK1 SMC5 ESF1 SART1 JUN BAZ1A EIF5B NOL7 BOD1L1 CDK11B SPEN NOL8 | 2.88e-06 | 1000 | 103 | 18 | int:SMC5 |
| Interaction | CEBPB interactions | CDK9 GTPBP4 RPL26 WBP11 AIMP1 BAZ1B XPC DCTN1 DDX27 LETM1 YARS1 RTF1 SART1 CCT6A JUN USO1 BAZ1A FAM50A TLN1 EIF5B NOL7 NBR1 | 3.00e-06 | 1443 | 103 | 22 | int:CEBPB |
| Interaction | TTN interactions | 3.11e-06 | 299 | 103 | 10 | int:TTN | |
| Interaction | ESF1 interactions | 4.34e-06 | 182 | 103 | 8 | int:ESF1 | |
| Interaction | MAP1LC3B interactions | WBP11 MAP1A RDX DCTN1 LETM1 GJA1 CCT6A RASAL3 USO1 BAZ1A DIAPH1 DIAPH3 NBR1 | 4.68e-06 | 551 | 103 | 13 | int:MAP1LC3B |
| Interaction | TERF2IP interactions | CDK9 WBP11 RBBP6 CHAF1A PSMD4 SREK1 RTF1 SART1 FAM50A TADA2B RNF20 BOD1L1 SPEN | 4.77e-06 | 552 | 103 | 13 | int:TERF2IP |
| Interaction | GTF2E2 interactions | 4.90e-06 | 185 | 103 | 8 | int:GTF2E2 | |
| Interaction | CBX3 interactions | CDK9 RBBP6 CHAF1A BAZ1B PSMD4 XPC SMC5 ESF1 RTF1 FAM50A DIAPH1 EIF5B SPEN NOL8 | 5.21e-06 | 646 | 103 | 14 | int:CBX3 |
| Interaction | SERF2 interactions | 5.56e-06 | 87 | 103 | 6 | int:SERF2 | |
| Interaction | H1-4 interactions | CDK9 GTPBP4 RPL26 WBP11 NOL12 BAZ1B SREK1 DDX27 GADD45GIP1 WDR87 RPL26L1 EIF5B CDK11B SPTY2D1 | 6.21e-06 | 656 | 103 | 14 | int:H1-4 |
| Interaction | MSN interactions | CDK9 CALD1 AIMP1 CNTRL RDX PPP2R5D TLN1 DIAPH1 CDK11B MYBPC2 | 7.42e-06 | 330 | 103 | 10 | int:MSN |
| Interaction | RPS6 interactions | CDK9 GTPBP4 RPL26 ERCC6 CHAF1A NOL12 NOL6 PSMD4 SREK1 DDX27 ESF1 RTF1 RPL26L1 EIF5B SPTY2D1 NOL8 | 8.92e-06 | 874 | 103 | 16 | int:RPS6 |
| Interaction | EED interactions | GTPBP4 RPL26 WBP11 MYO5B KDM5A RBBP6 NOL6 BAZ1B SMC5 DCTN1 DDX27 SART1 GJA1 CCT6A USO1 BAZ1A TLN1 ITSN2 EIF5B SPEN NBR1 | 1.10e-05 | 1445 | 103 | 21 | int:EED |
| Interaction | MAPRE1 interactions | GTPBP4 MAP9 ERCC6 BAZ1B DCTN1 JUN MAST4 CEP135 DIAPH1 EIF5B DIAPH3 NBR1 | 1.24e-05 | 514 | 103 | 12 | int:MAPRE1 |
| Interaction | MIPOL1 interactions | 1.32e-05 | 101 | 103 | 6 | int:MIPOL1 | |
| Interaction | SRPK2 interactions | CDK9 GTPBP4 WBP11 RBBP6 SREK1 DDX27 NPM2 RTF1 MIPOL1 SART1 BAZ1A RPL26L1 SPEN NOL8 | 1.69e-05 | 717 | 103 | 14 | int:SRPK2 |
| Interaction | NUP43 interactions | KDM5A RBBP6 NOL6 XPC SREK1 DDX27 RTF1 CCT6A BAZ1A RPL26L1 BOD1L1 CDK11B SPEN | 1.79e-05 | 625 | 103 | 13 | int:NUP43 |
| Interaction | DHX8 interactions | 1.90e-05 | 292 | 103 | 9 | int:DHX8 | |
| Interaction | ANKRD50 interactions | 1.93e-05 | 108 | 103 | 6 | int:ANKRD50 | |
| Interaction | PML interactions | RPL26 WBP11 ERCC6 CALD1 MAP1A RDX SMC5 SART1 CCT6A JUN DNAJC17 USO1 FAM50A TLN1 RNF20 CCDC102A | 2.00e-05 | 933 | 103 | 16 | int:PML |
| Interaction | WBP4 interactions | 2.04e-05 | 109 | 103 | 6 | int:WBP4 | |
| Interaction | NR2C2 interactions | GTPBP4 RPL26 AIMP1 KDM5A RBBP6 CHAF1A NOL6 BAZ1B RDX SREK1 CCDC12 SMC5 DDX27 YARS1 CCT6A ITSN2 DIAPH1 EIF5B NOL7 CDK11B | 2.45e-05 | 1403 | 103 | 20 | int:NR2C2 |
| Interaction | CUL7 interactions | GTPBP4 ERCC6 CALD1 MAP1A TRPS1 BAZ1B PSMD4 DDX27 SART1 CCT6A RPL26L1 TLN1 EIF5B NOL7 SPEN | 2.51e-05 | 845 | 103 | 15 | int:CUL7 |
| Interaction | H3-3A interactions | ERCC6 KDM5A CHAF1A BAZ1B DYNC2I1 XPC SMC5 BAZ1A FAM50A BRPF1 TADA2B BOD1L1 CDK11B SPEN | 2.73e-05 | 749 | 103 | 14 | int:H3-3A |
| Interaction | LRRC39 interactions | 2.76e-05 | 12 | 103 | 3 | int:LRRC39 | |
| Interaction | ST13P5 interactions | 2.76e-05 | 12 | 103 | 3 | int:ST13P5 | |
| Interaction | TXLNA interactions | 2.87e-05 | 236 | 103 | 8 | int:TXLNA | |
| Interaction | NOP56 interactions | GTPBP4 RPL26 ERCC6 NOL6 SMC5 DDX27 ESF1 RTF1 TMTC3 CDK11B SPTY2D1 NOL8 | 3.43e-05 | 570 | 103 | 12 | int:NOP56 |
| Interaction | NPM1 interactions | CDK9 GTPBP4 CHAF1A NOL12 NOL6 BAZ1B RDX PSMD4 XPC SREK1 SMC5 DDX27 ESF1 NPM2 WDR87 RPL26L1 SPTY2D1 HAND2 | 3.47e-05 | 1201 | 103 | 18 | int:NPM1 |
| Interaction | LMO7 interactions | 3.49e-05 | 177 | 103 | 7 | int:LMO7 | |
| Interaction | CEP290 interactions | 3.75e-05 | 179 | 103 | 7 | int:CEP290 | |
| Interaction | CIT interactions | CDK9 GTPBP4 RPL26 RBBP6 STXBP5 CHAF1A NOL6 BAZ1B SREK1 TTC3 DCTN1 ESF1 SART1 CCT6A RPL26L1 EIF5B NOL7 BOD1L1 CFAP53 CCDC40 | 3.91e-05 | 1450 | 103 | 20 | int:CIT |
| Interaction | PRPF8 interactions | RPL26 WBP11 ERCC6 AIMP1 RBBP6 CHAF1A SMC5 SART1 DNAJC17 FAM50A RNF20 EIF5B BOD1L1 SPEN | 4.02e-05 | 776 | 103 | 14 | int:PRPF8 |
| Interaction | POLR1G interactions | GTPBP4 WBP11 CHAF1A XPC DDX27 ESF1 RTF1 JUN FAM50A BRPF1 NOL8 | 4.10e-05 | 489 | 103 | 11 | int:POLR1G |
| Interaction | PPIA interactions | CDK9 CACNA1D ERCC6 MAP1A AIMP1 NOL6 PSMD4 SMC5 RTF1 JUN DNAJC17 BAZ1A FAM50A RNF20 DMD | 4.44e-05 | 888 | 103 | 15 | int:PPIA |
| Interaction | H3C3 interactions | GTPBP4 KDM5A CHAF1A BAZ1B XPC BAZ1A FAM50A BRPF1 NOL7 BOD1L1 SPEN | 4.58e-05 | 495 | 103 | 11 | int:H3C3 |
| Interaction | CKAP2 interactions | 4.62e-05 | 126 | 103 | 6 | int:CKAP2 | |
| Interaction | ZRSR2 interactions | 4.67e-05 | 77 | 103 | 5 | int:ZRSR2 | |
| Interaction | SUMO2 interactions | ERCC6 AIMP1 CHAF1A BAZ1B SMC5 SART1 CCT6A JUN BAZ1A TLN1 RNF20 BOD1L1 | 4.87e-05 | 591 | 103 | 12 | int:SUMO2 |
| Interaction | ZNF512 interactions | 5.11e-05 | 256 | 103 | 8 | int:ZNF512 | |
| Interaction | RNF113A interactions | GTPBP4 RPL26 AIMP1 RBBP6 TRPS1 RDX SREK1 DCTN1 DDX27 GADD45GIP1 SART1 DIAPH1 EIF5B | 5.15e-05 | 692 | 103 | 13 | int:RNF113A |
| Interaction | NOP2 interactions | CDK9 GTPBP4 RPL26 NOL12 NOL6 SMC5 DDX27 RPL26L1 SPTY2D1 NOL8 | 5.39e-05 | 416 | 103 | 10 | int:NOP2 |
| Interaction | USP36 interactions | GTPBP4 RPL26 NOL12 NOL6 PSMD4 SMC5 DDX27 ESF1 EIF5B NOL7 SPTY2D1 NOL8 | 5.54e-05 | 599 | 103 | 12 | int:USP36 |
| Interaction | PSENEN interactions | 5.95e-05 | 81 | 103 | 5 | int:PSENEN | |
| Interaction | KAT6A interactions | RPL26 CHAF1A NOL12 SREK1 DDX27 GADD45GIP1 ESF1 RTF1 RPL26L1 BRPF1 NOL7 | 5.99e-05 | 510 | 103 | 11 | int:KAT6A |
| Interaction | NPM3 interactions | 6.01e-05 | 262 | 103 | 8 | int:NPM3 | |
| Interaction | MYCN interactions | GTPBP4 RPL26 WBP11 AIMP1 RBBP6 NOL12 NOL6 BAZ1B CCDC12 DDX27 GADD45GIP1 ESF1 SART1 DNAJC17 RPL26L1 EIF5B NOL7 SPTY2D1 HAND2 | 6.04e-05 | 1373 | 103 | 19 | int:MYCN |
| Interaction | ABT1 interactions | GTPBP4 NOL12 NOL6 DDX27 GADD45GIP1 ESF1 RPL26L1 SPEN SPTY2D1 NOL8 | 6.19e-05 | 423 | 103 | 10 | int:ABT1 |
| Interaction | RPL23A interactions | CDK9 GTPBP4 RPL26 AIMP1 SREK1 DDX27 GADD45GIP1 OR10G4 MIPOL1 SART1 RPL26L1 OR10G9 | 6.20e-05 | 606 | 103 | 12 | int:RPL23A |
| Interaction | ZNF692 interactions | 6.20e-05 | 42 | 103 | 4 | int:ZNF692 | |
| Interaction | NUP50 interactions | 6.36e-05 | 341 | 103 | 9 | int:NUP50 | |
| Interaction | SURF6 interactions | 6.57e-05 | 426 | 103 | 10 | int:SURF6 | |
| Interaction | WAC interactions | 6.69e-05 | 83 | 103 | 5 | int:WAC | |
| Interaction | RPSA interactions | CDK9 GTPBP4 RPL26 NOL12 SREK1 SMC5 DDX27 SART1 CCT6A RPL26L1 NBR1 | 7.37e-05 | 522 | 103 | 11 | int:RPSA |
| Interaction | CCDC137 interactions | 7.57e-05 | 200 | 103 | 7 | int:CCDC137 | |
| Interaction | HNRNPCL2 interactions | 8.22e-05 | 274 | 103 | 8 | int:HNRNPCL2 | |
| Interaction | CHD4 interactions | GTPBP4 RPL26 WBP11 ERCC6 RBBP6 CHAF1A NOL6 TRPS1 BAZ1B SMC5 DCTN1 DDX27 SART1 CDK11B SPEN | 8.23e-05 | 938 | 103 | 15 | int:CHD4 |
| Interaction | ANOS1 interactions | 9.34e-05 | 143 | 103 | 6 | int:ANOS1 | |
| Interaction | FHDC1 interactions | 1.00e-04 | 18 | 103 | 3 | int:FHDC1 | |
| Interaction | ZBTB38 interactions | 1.01e-04 | 145 | 103 | 6 | int:ZBTB38 | |
| Interaction | RBM28 interactions | 1.14e-04 | 368 | 103 | 9 | int:RBM28 | |
| Interaction | FMNL3 interactions | 1.14e-04 | 49 | 103 | 4 | int:FMNL3 | |
| Interaction | PAF1 interactions | 1.15e-04 | 214 | 103 | 7 | int:PAF1 | |
| Interaction | FAM107B interactions | 1.18e-04 | 19 | 103 | 3 | int:FAM107B | |
| Interaction | GTSE1 interactions | 1.19e-04 | 215 | 103 | 7 | int:GTSE1 | |
| Interaction | COIL interactions | CDK9 GTPBP4 MYO5B AGGF1 XPC SMC5 YARS1 ESF1 RTF1 BRPF1 SPTY2D1 | 1.21e-04 | 552 | 103 | 11 | int:COIL |
| Interaction | ZNF346 interactions | 1.36e-04 | 377 | 103 | 9 | int:ZNF346 | |
| Interaction | DNAJB6 interactions | 1.42e-04 | 379 | 103 | 9 | int:DNAJB6 | |
| Interaction | ZC3H18 interactions | GTPBP4 RPL26 WBP11 AIMP1 RBBP6 CCDC12 SMC5 DDX27 RTF1 SART1 CCT6A RPL26L1 NOL7 SPEN | 1.48e-04 | 877 | 103 | 14 | int:ZC3H18 |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.17e-05 | 18 | 63 | 3 | 91 | |
| GeneFamily | PHD finger proteins | 2.73e-04 | 90 | 63 | 4 | 88 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CALD1 AIMP1 AGGF1 BAZ1B DYNC2I1 RDX UPF3A SREK1 ESF1 BAZ1A ITSN2 RNF20 EIF5B DIAPH3 FYB1 SKAP2 | 5.90e-09 | 656 | 103 | 16 | M18979 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | GTPBP4 AIMP1 RBBP6 TTC3 DDX27 YARS1 ESF1 MIPOL1 CCT6A USO1 ANKRD1 EIF5B BOD1L1 DIAPH3 NOL8 | 1.47e-07 | 721 | 103 | 15 | M10237 |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | WBP11 AIMP1 PSMD4 GADD45GIP1 RTF1 S100A13 BAZ1A FAM50A DIAPH1 EIF5B NOL7 CDK11B FYB1 | 8.45e-07 | 612 | 103 | 13 | MM3804 |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN | 1.28e-06 | 200 | 103 | 8 | M4979 | |
| Coexpression | LI_DCP2_BOUND_MRNA | 1.42e-06 | 89 | 103 | 6 | M2188 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | CACNA1D FSIP1 BAZ1B DYNC2I1 XPC SREK1 FMN1 MACROD2 EIF5B DMD | 5.90e-06 | 417 | 103 | 10 | M39224 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L KDM5A BAZ1B RDX SMC5 RGS7 GJA1 JUN BAZ1A ITSN2 CEP135 DMD SPEN SKAP2 | 6.57e-06 | 856 | 103 | 14 | M4500 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SECISBP2L WBP11 RBBP6 CNTRL TRPS1 PSMD4 UPF3A TTC3 DDX27 RGS7 CCT6A PPP2R5D BAZ1A DIAPH1 EIF5B NOL8 | 2.06e-05 | 1215 | 103 | 16 | M41122 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_UP | 2.88e-05 | 150 | 103 | 6 | M7001 | |
| Coexpression | GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP | 4.13e-05 | 160 | 103 | 6 | M339 | |
| Coexpression | IBRAHIM_NRF1_UP | 4.25e-05 | 420 | 103 | 9 | M42509 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_UP | 5.07e-05 | 166 | 103 | 6 | M17163 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_UP | 5.25e-05 | 167 | 103 | 6 | MM1057 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RPL26 KDM5A RBBP6 CEP85L CNTRL TRPS1 AGGF1 BAZ1B SMC5 RASAL3 BAZ1A TLN1 ITSN2 DIAPH1 BOD1L1 SPEN FYB1 | 6.87e-05 | 1492 | 103 | 17 | M40023 |
| Coexpression | BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP | 7.44e-05 | 21 | 103 | 3 | M17086 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 9.50e-05 | 269 | 103 | 7 | M41203 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 1.25e-04 | 378 | 103 | 8 | M41174 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP | 1.34e-04 | 66 | 103 | 4 | M1752 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP | 1.38e-04 | 199 | 103 | 6 | M4473 | |
| Coexpression | GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_DN | 1.42e-04 | 200 | 103 | 6 | M7748 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_UP | 1.42e-04 | 200 | 103 | 6 | M7749 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 1.48e-04 | 289 | 103 | 7 | M2196 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 1.83e-04 | 133 | 103 | 5 | M8880 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.86e-04 | 300 | 103 | 7 | M8702 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 1.97e-04 | 404 | 103 | 8 | M19488 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 2.11e-04 | 137 | 103 | 5 | MM990 | |
| Coexpression | LAKE_ADULT_KIDNEY_C1_EPITHELIAL_CELLS_UNASSIGNED | 2.21e-04 | 30 | 103 | 3 | M39220 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.43e-04 | 221 | 103 | 6 | M39222 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | KDM5A CEP85L BAZ1B SMC5 ESF1 SART1 JUN BAZ1A FMN1 CEP135 LRRCC1 EIF5B CDK11B NOL8 CCDC40 | 6.08e-09 | 469 | 101 | 15 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | RPL26 CALD1 UNCX CEP85L CNTRL TRPS1 BAZ1B DYNC2I1 RDX C10orf90 SREK1 SMC5 ESF1 MIPOL1 RASAL3 BAZ1A CEP135 LRRCC1 EIF5B BOD1L1 CDK11B HAND2 NOL8 CCDC40 | 6.97e-08 | 1468 | 101 | 24 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | RBBP6 CEP85L CNTRL TRPS1 BAZ1B DYNC2I1 RDX SREK1 SMC5 ESF1 BAZ1A TADA2B RNF20 CEP135 NINL LRRCC1 EIF5B BOD1L1 CDK11B DMD NOL8 CCDC40 | 8.46e-08 | 1257 | 101 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | GTPBP4 WBP11 ERCC6 MYO5B CEP85L SMC5 TTC3 ESF1 BAZ1A CEP135 NINL EIF5B NOL8 CCDC40 | 2.26e-07 | 532 | 101 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | UNCX RBBP6 CEP85L CNTRL TRPS1 BAZ1B DYNC2I1 RDX SREK1 SMC5 ESF1 BAZ1A TADA2B RNF20 CEP135 NINL LRRCC1 EIF5B BOD1L1 CDK11B DMD NOL8 CCDC40 | 2.66e-07 | 1459 | 101 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | RPL26 CALD1 CEP85L CNTRL TRPS1 BAZ1B DYNC2I1 RDX SREK1 SMC5 ESF1 MIPOL1 RASAL3 BAZ1A CEP135 LRRCC1 EIF5B BOD1L1 CDK11B NOL8 CCDC40 | 3.08e-07 | 1241 | 101 | 21 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | GTPBP4 RBBP6 BAZ1B SMC5 LETM1 ESF1 BAZ1A CEP135 BOD1L1 CDK11B | 2.33e-06 | 311 | 101 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.01e-06 | 186 | 101 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_500 | 3.76e-06 | 135 | 101 | 7 | gudmap_developingGonad_e11.5_testes and mesonephros_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 5.95e-06 | 204 | 101 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | CEP85L TRPS1 BAZ1B DYNC2I1 SMC5 ESF1 JUN RASAL3 BAZ1A BOD1L1 CDK11B | 6.69e-06 | 432 | 101 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | GTPBP4 RBBP6 STXBP5 BAZ1B UPF3A SMC5 LETM1 ESF1 BAZ1A CEP135 NINL BOD1L1 CDK11B DMD NOL8 | 8.81e-06 | 831 | 101 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.52e-05 | 232 | 101 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | MAP1A MYO5B RBBP6 CHAF1A TRPS1 DYNC2I1 SMC5 RASAL3 BAZ1A CEP135 LRRCC1 EIF5B CDK11B DMD FYB1 NOL8 | 1.56e-05 | 983 | 101 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | TRPS1 BAZ1B DYNC2I1 RASAL3 BAZ1A FMN1 CEP135 LRRCC1 BOD1L1 CDK11B HAND2 | 2.25e-05 | 492 | 101 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | MAP1A MYO5B CHAF1A DYNC2I1 SMC5 BAZ1A CEP135 EIF5B CDK11B DMD NOL8 | 2.29e-05 | 493 | 101 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CALD1 UNCX CEP85L CNTRL TRPS1 DYNC2I1 SREK1 SMC5 ESF1 MIPOL1 RASAL3 BAZ1A CEP135 LRRCC1 EIF5B BOD1L1 CDK11B CCDC40 | 2.30e-05 | 1252 | 101 | 18 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.31e-05 | 246 | 101 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 2.83e-05 | 124 | 101 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | UNCX MYO5B TRPS1 PARD3B SREK1 BAZ1A MACROD2 NINL TNNT2 FYB1 SKAP2 SPTY2D1 NOL8 FOXC2 | 4.12e-05 | 836 | 101 | 14 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | KDM5A BAZ1B DYNC2I1 SMC5 ESF1 SART1 JUN BAZ1A RNF20 BOD1L1 CDK11B DMD | 4.43e-05 | 629 | 101 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | WBP11 CALD1 UNCX BAZ1B PSMD4 SREK1 TTC3 DCTN1 GADD45GIP1 ESF1 GJA1 BAZ1A NBR1 FOXC2 | 4.50e-05 | 843 | 101 | 14 | gudmap_developingGonad_e11.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#3_top-relative-expression-ranked_500 | 6.54e-05 | 144 | 101 | 6 | gudmap_developingGonad_e11.5_testes_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | GTPBP4 MAP1A MYO5B RBBP6 BAZ1B SMC5 LETM1 ESF1 BAZ1A CEP135 NINL BOD1L1 CDK11B DMD NOL8 | 6.61e-05 | 989 | 101 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | ERCC6 CEP85L TRPS1 BAZ1B DYNC2I1 SMC5 ESF1 JUN RASAL3 BAZ1A FMN1 DIAPH1 NINL BOD1L1 CDK11B | 6.61e-05 | 989 | 101 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.59e-05 | 291 | 101 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.96e-05 | 293 | 101 | 8 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | MAP1A KDM5A CNTRL TRPS1 DYNC2I1 SMC5 ESF1 BAZ1A CEP135 LRRCC1 BOD1L1 CDK11B DMD NOL8 CCDC40 | 1.43e-04 | 1060 | 101 | 15 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.69e-04 | 327 | 101 | 8 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | WBP11 CALD1 BAZ1B PSMD4 SREK1 DCTN1 GADD45GIP1 ESF1 GJA1 BAZ1A NBR1 HAND2 FOXC2 | 1.82e-04 | 844 | 101 | 13 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500 | 2.39e-04 | 437 | 101 | 9 | gudmap_developingGonad_e11.5_testes_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | MAP1A CHAF1A CNTRL DYNC2I1 SMC5 TTC3 ESF1 GJA1 BAZ1A RNF20 CEP135 NINL LRRCC1 BOD1L1 CDK11B DMD CCDC40 | 2.40e-04 | 1370 | 101 | 17 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | WBP11 AGGF1 NKIRAS2 DDX27 ESF1 GJA1 PPP2R5D FMN1 LRRCC1 EIF5B CDK11B TNNT2 HAND2 CCDC40 | 2.55e-04 | 994 | 101 | 14 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.14e-04 | 192 | 101 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 3.14e-04 | 192 | 101 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.17e-04 | 124 | 101 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | RBBP6 STXBP5 BAZ1B DYNC2I1 UPF3A SMC5 LETM1 JUN MAST4 BAZ1A ITSN2 CDK11B | 3.31e-04 | 780 | 101 | 12 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.61e-04 | 197 | 101 | 6 | gudmap_developingGonad_e11.5_testes_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#2 | 4.08e-04 | 73 | 101 | 4 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_100 | 5.51e-04 | 79 | 101 | 4 | gudmap_developingKidney_e15.5_Podocyte cells_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.58e-04 | 298 | 101 | 7 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | 5.67e-04 | 492 | 101 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | TRPS1 BAZ1B DYNC2I1 RASAL3 BAZ1A FMN1 CEP135 LRRCC1 BOD1L1 CDK11B DMD FYB1 HAND2 | 7.40e-04 | 978 | 101 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_200 | 1.01e-03 | 160 | 101 | 5 | gudmap_developingKidney_e15.5_Podocyte cells_200 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | UNCX MAP1A KDM5A CNTRL TRPS1 DYNC2I1 SMC5 ESF1 BAZ1A CEP135 LRRCC1 BOD1L1 CDK11B DMD NOL8 CCDC40 | 1.01e-03 | 1414 | 101 | 16 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.02e-03 | 429 | 101 | 8 | gudmap_developingGonad_e14.5_ testes_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.12e-03 | 435 | 101 | 8 | gudmap_developingGonad_e11.5_testes and mesonephros_500 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | MAP9 ERICH3 CALD1 MAP1A DYNC2I1 ESF1 IGFBP5 TMTC3 EIF5B CDK11B DMD | 1.02e-12 | 194 | 103 | 11 | 8985095f291c1b54e45f4edece49aa26e8c8b732 |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.41e-11 | 197 | 103 | 10 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.59e-11 | 198 | 103 | 10 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 9.47e-10 | 199 | 103 | 9 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 9.47e-10 | 199 | 103 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-08 | 188 | 103 | 8 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 1.88e-08 | 196 | 103 | 8 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | H1299|World / Cell line, Condition and Strain | 2.20e-08 | 200 | 103 | 8 | 23f08d7cffacfced48785cd3ad230ecadb95713f | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-07 | 182 | 103 | 7 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-07 | 182 | 103 | 7 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-07 | 184 | 103 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 2.91e-07 | 189 | 103 | 7 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.13e-07 | 191 | 103 | 7 | cc9a6a8fad17d6e1a08a68ab7512ae06b1249051 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.13e-07 | 191 | 103 | 7 | c16b920ee69ea8536e020ac3475abf1ce972c1e6 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 3.60e-07 | 195 | 103 | 7 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.99e-07 | 198 | 103 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 4.12e-07 | 199 | 103 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.44e-06 | 176 | 103 | 6 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-06 | 178 | 103 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-06 | 185 | 103 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.72e-06 | 186 | 103 | 6 | c7885fd6dc7dc8fffc96f0112c51a365cf8a8f80 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-06 | 186 | 103 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 5.02e-06 | 188 | 103 | 6 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.02e-06 | 188 | 103 | 6 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 5.33e-06 | 190 | 103 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.50e-06 | 191 | 103 | 6 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.50e-06 | 191 | 103 | 6 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 5.50e-06 | 191 | 103 | 6 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-5|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 5.50e-06 | 191 | 103 | 6 | f2fe8fe316e449f452075aa37d5e31917221a335 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.66e-06 | 192 | 103 | 6 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.66e-06 | 192 | 103 | 6 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.83e-06 | 193 | 103 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-06 | 193 | 103 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-06 | 193 | 103 | 6 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.19e-06 | 195 | 103 | 6 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.19e-06 | 195 | 103 | 6 | 32ec72103faccc9e37c0ecedff1998e7df6a19f6 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 6.37e-06 | 196 | 103 | 6 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.56e-06 | 197 | 103 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ciliated-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.56e-06 | 197 | 103 | 6 | 62e20ef825b92908d7732aa625dcff7b95ef6ca8 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.56e-06 | 197 | 103 | 6 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.56e-06 | 197 | 103 | 6 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 6.75e-06 | 198 | 103 | 6 | f540f464118edc0fb809ebcb813d0302e6952253 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 199 | 103 | 6 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 6.95e-06 | 199 | 103 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 6.95e-06 | 199 | 103 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 6.95e-06 | 199 | 103 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 6.95e-06 | 199 | 103 | 6 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 199 | 103 | 6 | 2ed10c5e15c9d5ed0a8bea580842348d5698a07b | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 7.15e-06 | 200 | 103 | 6 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 7.15e-06 | 200 | 103 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-6|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.47e-06 | 119 | 103 | 5 | c1ca658c9f545ccbf3cf8fd034441cd5c9ef44b6 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.74e-05 | 138 | 103 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.33e-05 | 158 | 103 | 5 | 84c0a215dabf697ada036c2b9592d0c61b5077de | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.43e-05 | 159 | 103 | 5 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 4.33e-05 | 167 | 103 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | Ciliated_cells-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.71e-05 | 170 | 103 | 5 | 3d3a03979014df3a05c49be18010c6b94d786707 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-05 | 171 | 103 | 5 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-05 | 171 | 103 | 5 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 4.98e-05 | 172 | 103 | 5 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.98e-05 | 172 | 103 | 5 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.12e-05 | 173 | 103 | 5 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 176 | 103 | 5 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.71e-05 | 177 | 103 | 5 | c9b02a2e1ff2aa18c37e88a53b06a5b696a442ae | |
| ToppCell | Pericytes-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 5.86e-05 | 178 | 103 | 5 | a2448d868da2abe48c394c51264aad03e866dfec | |
| ToppCell | COPD-Stromal-SMC|World / Disease state, Lineage and Cell class | 6.02e-05 | 179 | 103 | 5 | b2709537ec1b46457ab85261f4cdd354e60a8b29 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 6.18e-05 | 180 | 103 | 5 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.18e-05 | 180 | 103 | 5 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-05 | 182 | 103 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.51e-05 | 182 | 103 | 5 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-05 | 183 | 103 | 5 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.68e-05 | 183 | 103 | 5 | 27a57cd8ea924420e182f3d72f5b29b00dea8fa0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.86e-05 | 184 | 103 | 5 | 30ca56d64c961127e26122613e35aa2b46fde2df | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 6.86e-05 | 184 | 103 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.04e-05 | 185 | 103 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-05 | 185 | 103 | 5 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.04e-05 | 185 | 103 | 5 | 11fbea1eb1d9a3e4480d0d2b0f7b02e2866b8142 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.04e-05 | 185 | 103 | 5 | 7460387f48f33674330bd53b759681b264228f5a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.22e-05 | 186 | 103 | 5 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-05 | 186 | 103 | 5 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.22e-05 | 186 | 103 | 5 | b5c1afbe065746ed662527b2f052321f200ba0a8 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-05 | 186 | 103 | 5 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.22e-05 | 186 | 103 | 5 | 26458ff8cad5577de4306cffa0ca69eb26940e0d | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.22e-05 | 186 | 103 | 5 | a71397efc68d2916ddc373d92cfd07be58033e1c | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.22e-05 | 186 | 103 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 187 | 103 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 187 | 103 | 5 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 187 | 103 | 5 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 7.40e-05 | 187 | 103 | 5 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 187 | 103 | 5 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.59e-05 | 188 | 103 | 5 | 82c006f43c93f4a867953a446864f02b44536a23 | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.59e-05 | 188 | 103 | 5 | bc0b9ba8ae88e8a89e98b446584ed39606e4229e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.59e-05 | 188 | 103 | 5 | da59b5c0a4b11690a39a964c1a0a83e66aa0972b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 7.59e-05 | 188 | 103 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.59e-05 | 188 | 103 | 5 | 0eca3dc93724e23b71e687fc24fa9f1e89bdef6a | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.59e-05 | 188 | 103 | 5 | 9ce3e1fffce87ad19812ecbf9b7f9935a975d676 | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.59e-05 | 188 | 103 | 5 | 50994e304c719f2f3c3232e48141e2dd15c96612 | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.59e-05 | 188 | 103 | 5 | a7b7ba56603a8a50869b41902aed6a9ab1c5c021 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.78e-05 | 189 | 103 | 5 | d69b7a01dd4d6ad043bb6210e9ab34b49578389c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.78e-05 | 189 | 103 | 5 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.78e-05 | 189 | 103 | 5 | 2b5f1b4f173a224342ea4f10b193ee33b7662699 | |
| Computational | Genes in the cancer module 192. | 5.60e-05 | 112 | 65 | 6 | MODULE_192 | |
| Computational | Genes in the cancer module 279. | 2.00e-04 | 141 | 65 | 6 | MODULE_279 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.09e-07 | 178 | 102 | 9 | 3998_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 2.56e-06 | 193 | 102 | 8 | 1081_DN | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HG-U133A | 2.98e-06 | 197 | 102 | 8 | 1941_DN | |
| Drug | norkurarinol | 1.99e-05 | 2 | 102 | 2 | ctd:C572712 | |
| Drug | kurarinone | 1.99e-05 | 2 | 102 | 2 | ctd:C411319 | |
| Drug | ascaridole | 1.99e-05 | 2 | 102 | 2 | ctd:C043372 | |
| Drug | Carbazoles | 1.99e-05 | 2 | 102 | 2 | ctd:D002227 | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.31e-05 | 189 | 102 | 7 | 1045_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.82e-05 | 195 | 102 | 7 | 6926_DN | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.91e-05 | 196 | 102 | 7 | 7124_DN | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; HL60; HG-U133A | 3.01e-05 | 197 | 102 | 7 | 1551_DN | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; PC3; HG-U133A | 3.01e-05 | 197 | 102 | 7 | 1930_DN | |
| Drug | Lansoprazole [103577-45-3]; Down 200; 10.8uM; PC3; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 7306_DN | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 1534_DN | |
| Drug | Gly-His-Lys acetate salt; Up 200; 1uM; PC3; HT_HG-U133A | 3.11e-05 | 198 | 102 | 7 | 6560_UP | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; PC3; HG-U133A | 3.21e-05 | 199 | 102 | 7 | 1950_DN | |
| Drug | AC1O4WL2 | 5.67e-05 | 17 | 102 | 3 | CID006420165 | |
| Disease | autosomal dominant auditory neuropathy 1 (implicated_via_orthology) | 3.34e-05 | 3 | 99 | 2 | DOID:0060690 (implicated_via_orthology) | |
| Disease | blindness (implicated_via_orthology) | 3.08e-04 | 8 | 99 | 2 | DOID:1432 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 4.10e-04 | 43 | 99 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | Familial dilated cardiomyopathy | 4.39e-04 | 44 | 99 | 3 | C0340427 | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 4.93e-04 | 10 | 99 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | Umbilical hernia | 6.01e-04 | 11 | 99 | 2 | HP_0001537 | |
| Disease | delta-6 desaturase measurement | 1.14e-03 | 15 | 99 | 2 | EFO_0007765 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.30e-03 | 16 | 99 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Tetralogy of Fallot | 1.30e-03 | 16 | 99 | 2 | C0039685 | |
| Disease | Malignant neoplasm of liver | 1.36e-03 | 142 | 99 | 4 | C0345904 | |
| Disease | Liver neoplasms | 1.36e-03 | 142 | 99 | 4 | C0023903 | |
| Disease | Craniofacial Abnormalities | 1.92e-03 | 156 | 99 | 4 | C0376634 | |
| Disease | Lung Neoplasms | 2.03e-03 | 265 | 99 | 5 | C0024121 | |
| Disease | Malignant neoplasm of lung | 2.06e-03 | 266 | 99 | 5 | C0242379 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.08e-03 | 75 | 99 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | intrinsic cardiomyopathy (implicated_via_orthology) | 2.24e-03 | 21 | 99 | 2 | DOID:0060036 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 2.46e-03 | 22 | 99 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | fat intake measurement | 2.46e-03 | 22 | 99 | 2 | EFO_0010809 | |
| Disease | Cardiac Hypertrophy | 2.68e-03 | 82 | 99 | 3 | C1383860 | |
| Disease | Cardiomegaly | 2.68e-03 | 82 | 99 | 3 | C0018800 | |
| Disease | congestive heart failure (is_marker_for) | 2.68e-03 | 82 | 99 | 3 | DOID:6000 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | 3.27e-03 | 1074 | 99 | 10 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FIEDRVKKIIELKRK | 266 | P40227 | |
| LEIKKKLETLARKER | 86 | Q5RHP9 | |
| LRELEKKKKLEDAKS | 951 | Q7Z7A1 | |
| REKLKLEEEKKKKLE | 46 | Q86SG2 | |
| KEKEREREKQKLKES | 586 | Q5VTR2 | |
| LKRAEDKAKLKELEK | 236 | Q14203 | |
| REAELKKKKLEQRSK | 66 | Q15327 | |
| EQRKEYLKKKREELK | 541 | Q9UIG0 | |
| REELKKKLKEKAKER | 551 | Q9UIG0 | |
| KKLRVENAKLKKEIE | 46 | Q12904 | |
| QIREKKKLKILESKE | 486 | Q9BZE4 | |
| DIKKEKVLLRRKSEL | 561 | Q14738 | |
| KEEKELERRKELKKI | 551 | Q8N302 | |
| KDKKTDEIVALKRLK | 456 | P21127 | |
| KIKEIDRELQKKKEE | 1911 | P11532 | |
| LKEKERREKREKDEK | 381 | Q13111 | |
| EAKLEEKRKKEEEKR | 416 | Q13111 | |
| KLAKEKAEKERLEKQ | 1166 | O60610 | |
| IKKREAEEKEKRVRI | 1016 | Q9NSV4 | |
| TLDEKIEKVRKKRKT | 116 | Q96GQ7 | |
| IEKVRKKRKTEDKEA | 121 | Q96GQ7 | |
| KEERKKEKIAKALQE | 656 | Q96GQ7 | |
| KKARVLSKKEERLKK | 316 | Q03468 | |
| ELKKIVEEERLKKKE | 351 | Q9NRL2 | |
| LKKKEEKERLKVERE | 361 | Q9NRL2 | |
| ERSKKKVKQDLLELK | 381 | Q9H095 | |
| KRLKEKKKARLEPRD | 206 | Q86YV0 | |
| KRKVERKKAAIEEIK | 36 | Q9UGY1 | |
| VKFEDLIKDLRKLKR | 1261 | Q68DA7 | |
| KIKRDKLKEIERKRL | 666 | Q9NZM3 | |
| EKKKREIAEKEKERI | 326 | P35241 | |
| KKARVLSKKEERLKK | 316 | P0DP91 | |
| RKEENEDPERKIKKK | 856 | Q8TEW8 | |
| NKEVKKAVLKLRDKV | 291 | Q8NGN3 | |
| EALKAEKRKLIKDKV | 386 | P78559 | |
| EKEAKKIAAKKRLEE | 481 | Q49MG5 | |
| KEKINEKRKEELKRA | 576 | Q49MG5 | |
| KEDKEQRKLKFKLEL | 136 | Q8TD10 | |
| KRKLERIARLEEKVK | 271 | P05412 | |
| RVELLKKEIDKFKDK | 96 | Q9NYS0 | |
| KEERLKKELRVKLEL | 246 | O95202 | |
| KEERKHREKKLRKES | 31 | Q8WVS4 | |
| EKKRLKRKQKALAEE | 641 | Q9H501 | |
| REKKREKEEKKRLEL | 471 | O15117 | |
| LLKEVRLSEKKKDRI | 91 | Q9H6R4 | |
| RVELLKKEIDKSKDK | 96 | Q9NYR9 | |
| ELKAEAVKKDRRKKL | 146 | P24593 | |
| RRFKKKDVSKEKEER | 166 | Q99958 | |
| KRKKKREEAEKLPEV | 971 | Q76FK4 | |
| GKNRRKKVKELIEKE | 1086 | P29375 | |
| RRLKEEEKKKSKLDE | 646 | Q7Z6E9 | |
| KTLLKEKRKRREELF | 91 | Q9UMY1 | |
| IKKTDVKEEKRKKEL | 171 | P61296 | |
| VKEEKRKKELNEILK | 176 | P61296 | |
| IKEVLKERKVLEKKV | 556 | Q8NFC6 | |
| REKTKLLKEKNEKER | 131 | Q96M91 | |
| DKELGEAKKEIKRKL | 341 | Q66GS9 | |
| LEKLREKERKKEAKR | 101 | Q14320 | |
| EKERKKEAKRKISSL | 106 | Q14320 | |
| KKLRVESKIEQEKKE | 811 | Q4G0X9 | |
| AEVKKLRLRVEELKK | 451 | Q96A19 | |
| RKEEKLNKKEEELKV | 101 | P17302 | |
| EEKKKLEEKLKTRDR | 471 | Q5SZL2 | |
| TQKLDEKRKKVKLDL | 86 | Q9NVM6 | |
| DLDRDKLKAKVVVKK | 1526 | O15021 | |
| DKILAKKQRREKEIK | 126 | Q8NA03 | |
| DLEKKERKRLKEEKQ | 181 | Q8TAE8 | |
| LKRDVAKKLEKLKKR | 116 | Q8WUD4 | |
| ELVKGQKRKVKDRLK | 266 | P50750 | |
| KLAKRLKKEKVNVDI | 126 | P55036 | |
| AKKKKLEKEEEEIRA | 176 | Q86SE8 | |
| KEEAEEKERKKIARK | 766 | Q01668 | |
| KEEERLEALKGKIKK | 31 | Q9BV36 | |
| NKEVKKAVLKLRDKV | 291 | Q8NGN4 | |
| LDKDRKKILERKAKS | 111 | Q9UNX3 | |
| KKKKVWREEKERLLK | 6 | A1Z1Q3 | |
| EVLKRRFEIKKKLKT | 216 | Q92541 | |
| LKKVEDKRIRKLKNE | 31 | Q8TDW5 | |
| KEKLKQLIEKRIGKE | 561 | O60763 | |
| KVDKKRDKIERKILD | 176 | P49802 | |
| KIDLLDRKEDVKKKL | 231 | P54577 | |
| EKALKRKITKEEKEL | 241 | Q86TJ2 | |
| GELAKEIRKKKDLKI | 81 | Q99584 | |
| RAEKKQRKAEVKELK | 306 | Q14596 | |
| AKEKRESLIKKIKDV | 41 | O75563 | |
| QKKIAEKEVRIKLLK | 271 | Q9H1J1 | |
| KERERKKRDEEKAKL | 236 | O60841 | |
| EKAKLRKLKEKEELE | 246 | O60841 | |
| ERKERLKKEGKLLTK | 396 | O60841 | |
| KKVILKEREEKKGRL | 576 | Q93073 | |
| RKDTREKIKEKERVK | 261 | Q8WXA9 | |
| EKIKEKERVKEKDRE | 266 | Q8WXA9 | |
| AQRKEIEVLKKDKEK | 1116 | Q9Y2I6 | |
| EKDEKEKLKKRRPVS | 886 | Q5T5C0 | |
| EEKRRKEELVKKRIE | 61 | Q68D10 | |
| ELIRKREKLKRETIK | 606 | P55201 | |
| EELKKKREERRKVLE | 566 | Q05682 | |
| LLRKLKEKEEVIKEL | 206 | Q8IYJ2 | |
| EVKKKKEEQRKRVIL | 661 | Q96M02 | |
| KREKLEEKDGLKEKV | 766 | Q9UHF7 | |
| RKEILKRESKKIKLD | 1041 | Q96T58 | |
| RKDKTLLRDEKKMEK | 146 | Q9Y490 | |
| LDKDRKKILERKAKS | 111 | P61254 | |
| EKKKKILAERRKVLA | 216 | P45379 | |
| EKLRLKEDKKLKRKI | 761 | P53804 | |
| VKKIRKKEKEVVVRA | 406 | O43290 | |
| KVLKDKRKKLRETFE | 76 | Q9Y2W2 | |
| VIERKEKEKKEKRAL | 831 | Q01831 | |
| IKEIEKKRVAALKRL | 891 | Q6ZXV5 | |
| KLVRDRVKEEVRKLK | 286 | Q8IY18 | |
| ELTKDEKKLARKQRK | 2131 | Q6ZQQ6 | |
| EIARKELEKMEKKKR | 191 | A6NJT0 | |
| KEKKLKAERDKSIEL | 931 | Q9C099 | |
| ELVEKLEKNERKLKK | 1411 | Q9ULV0 | |
| GLLKKREVVEEEKKK | 186 | Q14324 |